Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Orthofix Medical Inc. (OFIX)

Orthofix raises 2026 guidance as Q2 sales rise 3.8% and net loss widens to $15.8 million

Mixed Impact 4 of 5 earnings Written later

Orthofix reported second-quarter 2026 net sales of $210.9 million, up 3.8% from a year earlier, but its net loss widened to $15.8 million from $14.1 million and adjusted EBITDA fell to $20.1 million from $20.6 million. The company raised its full-year 2026 guidance for net sales and adjusted EBITDA, but cash declined to $104.4 million as it made arbitration award and settlement payments to three former executives.

Key points

  • Q2 2026 net sales were $210.9 million, up 3.8% reported and 4.7% pro forma constant currency versus Q2 2025.
  • Q2 net loss was $(15.8) million, or $(0.39) per share, compared with $(14.1) million, or $(0.36) per share, a year earlier.
  • 2026 guidance raised: net sales to $845 million–$855 million (from $838 million–$848 million) and adjusted EBITDA to $95 million–$98 million (from $90 million–$93 million), both set May 21, 2026.
  • Cash, cash equivalents and restricted cash fell to $104.4 million on June 30, 2026, from $120.9 million on March 31, 2026.

The filing

CompanyOrthofix Medical Inc. (OFIX)
Form8-K, current report
Filed with the SECAug 5, 2026, 7:03 AM ET
Accession number0001193125-26-333817

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.